BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

364 related articles for article (PubMed ID: 29449279)

  • 1. MRI with DWI for the Detection of Posttreatment Head and Neck Squamous Cell Carcinoma: Why Morphologic MRI Criteria Matter.
    Ailianou A; Mundada P; De Perrot T; Pusztaszieri M; Poletti PA; Becker M
    AJNR Am J Neuroradiol; 2018 Apr; 39(4):748-755. PubMed ID: 29449279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Utility of MRI with morphologic and diffusion weighted imaging in the detection of post-treatment nodal disease in head and neck squamous cell carcinoma.
    Mundada P; Varoquaux AD; Lenoir V; de Vito C; Dulguerov N; Ailianou A; Caparrotti F; Becker M
    Eur J Radiol; 2018 Apr; 101():162-169. PubMed ID: 29571791
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Local recurrence of squamous cell carcinoma of the head and neck after radio(chemo)therapy: Diagnostic performance of FDG-PET/MRI with diffusion-weighted sequences.
    Becker M; Varoquaux AD; Combescure C; Rager O; Pusztaszeri M; Burkhardt K; Delattre BMA; Dulguerov P; Dulguerov N; Katirtzidou E; Caparrotti F; Ratib O; Zaidi H; Becker CD
    Eur Radiol; 2018 Feb; 28(2):651-663. PubMed ID: 28812148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of recurrent tumor and posttreatment changes in head and neck squamous cell carcinoma: application of high b-value diffusion-weighted imaging.
    Hwang I; Choi SH; Kim YJ; Kim KG; Lee AL; Yun TJ; Kim JH; Sohn CH
    AJNR Am J Neuroradiol; 2013 Dec; 34(12):2343-8. PubMed ID: 23811978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of Diffusion-Weighted Imaging and
    Noij DP; Martens RM; Koopman T; Hoekstra OS; Comans EFI; Zwezerijnen B; de Bree R; de Graaf P; Castelijns JA
    Clin Oncol (R Coll Radiol); 2018 Dec; 30(12):780-792. PubMed ID: 30318343
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of Local Recurrence in Patients with Head and Neck Squamous Cell Carcinoma Using Voxel-Based Color Maps of Initial and Final Area under the Curve Values Derived from DCE-MRI.
    Lee JY; Cheng KL; Lee JH; Choi YJ; Kim HW; Sung YS; Chung SR; Ryu KH; Chung MS; Kim SY; Lee SW; Baek JH
    AJNR Am J Neuroradiol; 2019 Aug; 40(8):1392-1401. PubMed ID: 31320461
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of diffusion-weighted MR imaging and
    Schroeder C; Lee JH; Tetzner U; Seidel S; Kim SY
    Eur J Radiol; 2020 Sep; 130():109157. PubMed ID: 32652403
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-Weighted Imaging (DWI) derived from PET/MRI for lymph node assessment in patients with Head and Neck Squamous Cell Carcinoma (HNSCC).
    Freihat O; Pinter T; Kedves A; Sipos D; Cselik Z; Repa I; Kovács Á
    Cancer Imaging; 2020 Aug; 20(1):56. PubMed ID: 32771060
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MRI Posttreatment Surveillance for Head and Neck Squamous Cell Carcinoma: Proposed MR NI-RADS Criteria.
    Ashour MM; Darwish EAF; Fahiem RM; Abdelaziz TT
    AJNR Am J Neuroradiol; 2021 Jun; 42(6):1123-1129. PubMed ID: 33707288
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic value of diffusion-weighted imaging and
    Noij DP; Martens RM; Zwezerijnen B; Koopman T; de Bree R; Hoekstra OS; de Graaf P; Castelijns JA
    Eur J Radiol; 2018 Oct; 107():20-25. PubMed ID: 30292267
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Value of diffusion MR imaging in differentiation of recurrent head and neck malignancies from post treatment changes.
    Jajodia A; Aggarwal D; Chaturvedi AK; Rao A; Mahawar V; Gairola M; Agarwal M; Goyal S; Koyyala VPB; Pasricha S; Tripathi R
    Oral Oncol; 2019 Sep; 96():89-96. PubMed ID: 31422219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of Local Tumor Recurrence After Definitive Treatment of Head and Neck Squamous Cell Carcinoma: Histogram Analysis of Dynamic Contrast-Enhanced T1-Weighted Perfusion MRI.
    Choi SH; Lee JH; Choi YJ; Park JE; Sung YS; Kim N; Baek JH
    AJR Am J Roentgenol; 2017 Jan; 208(1):42-47. PubMed ID: 27680294
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differentiating recurrent tumours from post-treatment changes in head and neck cancers: does diffusion-weighted MRI solve the eternal dilemma?
    Vaid S; Chandorkar A; Atre A; Shah D; Vaid N
    Clin Radiol; 2017 Jan; 72(1):74-83. PubMed ID: 27789026
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictive value of quantitative diffusion-weighted imaging and 18-F-FDG-PET in head and neck squamous cell carcinoma treated by (chemo)radiotherapy.
    Martens RM; Noij DP; Koopman T; Zwezerijnen B; Heymans M; de Jong MC; Hoekstra OS; Vergeer MR; de Bree R; Leemans CR; de Graaf P; Boellaard R; Castelijns JA
    Eur J Radiol; 2019 Apr; 113():39-50. PubMed ID: 30927958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High b-Value Diffusion MRI to Differentiate Recurrent Tumors from Posttreatment Changes in Head and Neck Squamous Cell Carcinoma: A Single Center Prospective Study.
    Acampora A; Manzo G; Fenza G; Busto G; Serino A; Manto A
    Biomed Res Int; 2016; 2016():2865169. PubMed ID: 27376081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histogram analysis parameters identify multiple associations between DWI and DCE MRI in head and neck squamous cell carcinoma.
    Meyer HJ; Leifels L; Schob S; Garnov N; Surov A
    Magn Reson Imaging; 2018 Jan; 45():72-77. PubMed ID: 28963049
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pretreatment ADC is not a prognostic factor for local recurrences in head and neck squamous cell carcinoma when clinical T-stage is known.
    Peltenburg B; Driessen JP; Vasmel JE; Pameijer FA; Janssen LM; Terhaard CHJ; de Bree R; Philippens MEP
    Eur Radiol; 2020 Feb; 30(2):1228-1231. PubMed ID: 31529258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adding MR Diffusion Imaging and T2 Signal Intensity to Neck Imaging Reporting and Data System Categories 2 and 3 in Primary Sites of Postsurgical Oral Cavity Carcinoma Provides Incremental Diagnostic Value.
    Jajodia A; Mandal G; Yadav V; Khoda J; Goyal J; Pasricha S; Puri S; Dewan A
    AJNR Am J Neuroradiol; 2022 Jul; 43(7):1018-1023. PubMed ID: 35738671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion-weighted magnetic resonance imaging early after chemoradiotherapy to monitor treatment response in head-and-neck squamous cell carcinoma.
    Vandecaveye V; Dirix P; De Keyzer F; Op de Beeck K; Vander Poorten V; Hauben E; Lambrecht M; Nuyts S; Hermans R
    Int J Radiat Oncol Biol Phys; 2012 Mar; 82(3):1098-107. PubMed ID: 21514067
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion tensor imaging in differentiation of residual head and neck squamous cell carcinoma from post-radiation changes.
    Abdel Razek AAK
    Magn Reson Imaging; 2018 Dec; 54():84-89. PubMed ID: 30142392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.